365 related articles for article (PubMed ID: 21482645)
1. Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
Kusari J; Padillo E; Zhou SX; Bai Y; Wang J; Song Z; Zhu M; Le YZ; Gil DW
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5424-31. PubMed ID: 21482645
[TBL] [Abstract][Full Text] [Related]
2. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Delivery of VEGF-A
Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
5. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
7. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.
Rabinowitz R; Katz G; Rosner M; Pri-Chen S; Spierer A
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):843-8. PubMed ID: 18343940
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
Barnett JM; McCollum GW; Fowler JA; Duan JJ; Kay JD; Liu RQ; Bingaman DP; Penn JS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):907-15. PubMed ID: 17251494
[TBL] [Abstract][Full Text] [Related]
11. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Eyetech Study Group
Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization.
Zhao M; Xie W; Tsai SH; Hein TW; Rocke BA; Kuo L; Rosa RH
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1125-1133. PubMed ID: 29490350
[TBL] [Abstract][Full Text] [Related]
13. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy.
Sheibani N; Zaitoun IS; Wang S; Darjatmoko SR; Suscha A; Song YS; Sorenson CM; Shifrin V; Albert DM; Melgar-Asensio I; Kandela I; Henkin J
Exp Eye Res; 2020 Jun; 195():108030. PubMed ID: 32272114
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity.
Fawzi AA; Chou JC; Kim GA; Rollins SD; Taylor JM; Farrow KN
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1493-501. PubMed ID: 24519428
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model.
Ishida K; Yoshimura N; Mandai M; Honda Y
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1512-9. PubMed ID: 10359334
[TBL] [Abstract][Full Text] [Related]
17. Guanabenz and Clonidine, α2-Adrenergic Receptor Agonists, Inhibit Choroidal Neovascularization.
Tanaka M; Inoue Y; Imai T; Tanida N; Takahashi K; Hara H
Curr Neurovasc Res; 2021; 18(1):85-92. PubMed ID: 34011258
[TBL] [Abstract][Full Text] [Related]
18. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
Kociok N; Krohne TU; Poulaki V; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
[TBL] [Abstract][Full Text] [Related]
19. Baicalin attenuates laser-induced choroidal neovascularization.
Yang SJ; Jo H; Kim JG; Jung SH
Curr Eye Res; 2014 Jul; 39(7):745-51. PubMed ID: 24502359
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
Song JH; Moon KY; Lee SC; Kim SS
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
